BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 29019492)

  • 1. Self-assembling prodrugs.
    Cheetham AG; Chakroun RW; Ma W; Cui H
    Chem Soc Rev; 2017 Oct; 46(21):6638-6663. PubMed ID: 29019492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells.
    Su H; Zhang P; Cheetham AG; Koo JM; Lin R; Masood A; Schiapparelli P; Quiñones-Hinojosa A; Cui H
    Theranostics; 2016; 6(7):1065-74. PubMed ID: 27217839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials.
    Nguyen A; Böttger R; Li SD
    Biomaterials; 2021 Aug; 275():120955. PubMed ID: 34130143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering.
    Chakroun RW; Wang F; Lin R; Wang Y; Su H; Pompa D; Cui H
    ACS Nano; 2019 Jul; 13(7):7780-7790. PubMed ID: 31117370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrugs as self-assembled hydrogels: a new paradigm for biomaterials.
    Vemula PK; Wiradharma N; Ankrum JA; Miranda OR; John G; Karp JM
    Curr Opin Biotechnol; 2013 Dec; 24(6):1174-82. PubMed ID: 23465753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in prodrugs as drug delivery systems.
    Lin C; Sunkara G; Cannon JB; Ranade V
    Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs as drug delivery system in oncology.
    Delahousse J; Skarbek C; Paci A
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):937-958. PubMed ID: 31392391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodrugs: a challenge for the drug development.
    Zawilska JB; Wojcieszak J; Olejniczak AB
    Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy Landscapes of Supramolecular Peptide-Drug Conjugates Directed by Linker Selection and Drug Topology.
    Sis MJ; Ye Z; La Costa K; Webber MJ
    ACS Nano; 2022 Jun; 16(6):9546-9558. PubMed ID: 35639629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
    Jana S; Mandlekar S; Marathe P
    Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery.
    Wang Z; Chen J; Little N; Lu J
    Acta Biomater; 2020 Jul; 111():20-28. PubMed ID: 32454086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrugs: design and clinical applications.
    Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
    Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supramolecular prodrugs based on host-guest interactions.
    Geng WC; Sessler JL; Guo DS
    Chem Soc Rev; 2020 Apr; 49(8):2303-2315. PubMed ID: 32181453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembling nanomicelles of a novel camptothecin prodrug engineered with a redox-responsive release mechanism.
    Li XQ; Wen HY; Dong HQ; Xue WM; Pauletti GM; Cai XJ; Xia WJ; Shi D; Li YY
    Chem Commun (Camb); 2011 Aug; 47(30):8647-9. PubMed ID: 21725532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is prodrug design an approach to increase water solubility?
    Sanches BMA; Ferreira EI
    Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticles as delivery carriers for anticancer prodrugs.
    Fang JY; Al-Suwayeh SA
    Expert Opin Drug Deliv; 2012 Jun; 9(6):657-69. PubMed ID: 22507134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
    Krise JP; Charman WN; Charman SA; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
    Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
    Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodrug strategy for enhancing drug delivery via skin.
    Fang JY; Leu YL
    Curr Drug Discov Technol; 2006 Sep; 3(3):211-24. PubMed ID: 17311566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.